We regret to inform you that the publisher of this article, Oxford University Press, has removed this article from DeepDyve.

Occasionally, journals transition between publishers. This article may be available on DeepDyve from the journal's new publisher.


Find the current version of this article on DeepDyve

ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients
Trédan, O; Ménétrier-Caux, C; Ray-Coquard, I; Garin, G; Cropet, C; Verronèse, E; Bachelot, T; Rebattu, P; Heudel, P E; Cassier, P; Chabaud, S; Croughs, T; Dupont, P; Cadore, A C; Clapisson, G; Delgado, A; Bardin-dit-Courageot, C; Rigal, C; N’Kodia, A; Gilles-Afchain, L; Morre, M; Pérol, D; Blay, J Y; Caux, C Annals of Oncology. 2018.
Find this article